Cargando…
Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis
OBJECTIVE: To assess whether chronic white matter inflammation in patients with multiple sclerosis (MS) as detected in vivo by paramagnetic rim MRI lesions (PRLs) is associated with higher serum neurofilament light chain (sNfL) levels, a marker of neuroaxonal damage. METHODS: In 118 patients with MS...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424501/ https://www.ncbi.nlm.nih.gov/pubmed/34088875 http://dx.doi.org/10.1212/WNL.0000000000012326 |
_version_ | 1783749687143038976 |
---|---|
author | Maggi, Pietro Kuhle, Jens Schädelin, Sabine van der Meer, Franziska Weigel, Matthias Galbusera, Riccardo Mathias, Amandine Lu, Po-Jui Rahmanzadeh, Reza Benkert, Pascal La Rosa, Francesco Bach Cuadra, Meritxell Sati, Pascal Théaudin, Marie Pot, Caroline van Pesch, Vincent Leppert, David Stadelmann, Christine Kappos, Ludwig Du Pasquier, Renaud Reich, Daniel S. Absinta, Martina Granziera, Cristina |
author_facet | Maggi, Pietro Kuhle, Jens Schädelin, Sabine van der Meer, Franziska Weigel, Matthias Galbusera, Riccardo Mathias, Amandine Lu, Po-Jui Rahmanzadeh, Reza Benkert, Pascal La Rosa, Francesco Bach Cuadra, Meritxell Sati, Pascal Théaudin, Marie Pot, Caroline van Pesch, Vincent Leppert, David Stadelmann, Christine Kappos, Ludwig Du Pasquier, Renaud Reich, Daniel S. Absinta, Martina Granziera, Cristina |
author_sort | Maggi, Pietro |
collection | PubMed |
description | OBJECTIVE: To assess whether chronic white matter inflammation in patients with multiple sclerosis (MS) as detected in vivo by paramagnetic rim MRI lesions (PRLs) is associated with higher serum neurofilament light chain (sNfL) levels, a marker of neuroaxonal damage. METHODS: In 118 patients with MS with no gadolinium-enhancing lesions or recent relapses, we analyzed 3D-submillimeter phase MRI and sNfL levels. Histopathologic evaluation was performed in 25 MS lesions from 20 additional autopsy MS cases. RESULTS: In univariable analyses, participants with ≥2 PRLs (n = 43) compared to those with ≤1 PRL (n = 75) had higher age-adjusted sNfL percentiles (median, 91 and 68; p < 0.001) and higher Multiple Sclerosis Severity Scale scores (MSSS median, 4.3 and 2.4; p = 0.003). In multivariable analyses, sNfL percentile levels were higher in PRLs ≥2 cases (β(add), 16.3; 95% confidence interval [CI], 4.6–28.0; p < 0.01), whereas disease-modifying treatment (DMT), Expanded Disability Status Scale (EDSS) score, and T2 lesion load did not affect sNfL. In a similar model, sNfL percentile levels were highest in cases with ≥4 PRLs (n = 30; β(add), 30.4; 95% CI, 15.6–45.2; p < 0.01). Subsequent multivariable analysis revealed that PRLs ≥2 cases also had higher MSSS (β(add), 1.1; 95% CI, 0.3–1.9; p < 0.01), whereas MSSS was not affected by DMT or T2 lesion load. On histopathology, both chronic active and smoldering lesions exhibited more severe acute axonal damage at the lesion edge than in the lesion center (edge vs center: p = 0.004 and p = 0.0002, respectively). CONCLUSION: Chronic white matter inflammation was associated with increased levels of sNfL and disease severity in nonacute MS, suggesting that PRL contribute to clinically relevant, inflammation-driven neurodegeneration. |
format | Online Article Text |
id | pubmed-8424501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-84245012021-09-08 Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis Maggi, Pietro Kuhle, Jens Schädelin, Sabine van der Meer, Franziska Weigel, Matthias Galbusera, Riccardo Mathias, Amandine Lu, Po-Jui Rahmanzadeh, Reza Benkert, Pascal La Rosa, Francesco Bach Cuadra, Meritxell Sati, Pascal Théaudin, Marie Pot, Caroline van Pesch, Vincent Leppert, David Stadelmann, Christine Kappos, Ludwig Du Pasquier, Renaud Reich, Daniel S. Absinta, Martina Granziera, Cristina Neurology Research Article OBJECTIVE: To assess whether chronic white matter inflammation in patients with multiple sclerosis (MS) as detected in vivo by paramagnetic rim MRI lesions (PRLs) is associated with higher serum neurofilament light chain (sNfL) levels, a marker of neuroaxonal damage. METHODS: In 118 patients with MS with no gadolinium-enhancing lesions or recent relapses, we analyzed 3D-submillimeter phase MRI and sNfL levels. Histopathologic evaluation was performed in 25 MS lesions from 20 additional autopsy MS cases. RESULTS: In univariable analyses, participants with ≥2 PRLs (n = 43) compared to those with ≤1 PRL (n = 75) had higher age-adjusted sNfL percentiles (median, 91 and 68; p < 0.001) and higher Multiple Sclerosis Severity Scale scores (MSSS median, 4.3 and 2.4; p = 0.003). In multivariable analyses, sNfL percentile levels were higher in PRLs ≥2 cases (β(add), 16.3; 95% confidence interval [CI], 4.6–28.0; p < 0.01), whereas disease-modifying treatment (DMT), Expanded Disability Status Scale (EDSS) score, and T2 lesion load did not affect sNfL. In a similar model, sNfL percentile levels were highest in cases with ≥4 PRLs (n = 30; β(add), 30.4; 95% CI, 15.6–45.2; p < 0.01). Subsequent multivariable analysis revealed that PRLs ≥2 cases also had higher MSSS (β(add), 1.1; 95% CI, 0.3–1.9; p < 0.01), whereas MSSS was not affected by DMT or T2 lesion load. On histopathology, both chronic active and smoldering lesions exhibited more severe acute axonal damage at the lesion edge than in the lesion center (edge vs center: p = 0.004 and p = 0.0002, respectively). CONCLUSION: Chronic white matter inflammation was associated with increased levels of sNfL and disease severity in nonacute MS, suggesting that PRL contribute to clinically relevant, inflammation-driven neurodegeneration. Lippincott Williams & Wilkins 2021-08-10 /pmc/articles/PMC8424501/ /pubmed/34088875 http://dx.doi.org/10.1212/WNL.0000000000012326 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Research Article Maggi, Pietro Kuhle, Jens Schädelin, Sabine van der Meer, Franziska Weigel, Matthias Galbusera, Riccardo Mathias, Amandine Lu, Po-Jui Rahmanzadeh, Reza Benkert, Pascal La Rosa, Francesco Bach Cuadra, Meritxell Sati, Pascal Théaudin, Marie Pot, Caroline van Pesch, Vincent Leppert, David Stadelmann, Christine Kappos, Ludwig Du Pasquier, Renaud Reich, Daniel S. Absinta, Martina Granziera, Cristina Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis |
title | Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis |
title_full | Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis |
title_fullStr | Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis |
title_full_unstemmed | Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis |
title_short | Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis |
title_sort | chronic white matter inflammation and serum neurofilament levels in multiple sclerosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424501/ https://www.ncbi.nlm.nih.gov/pubmed/34088875 http://dx.doi.org/10.1212/WNL.0000000000012326 |
work_keys_str_mv | AT maggipietro chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT kuhlejens chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT schadelinsabine chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT vandermeerfranziska chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT weigelmatthias chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT galbuserariccardo chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT mathiasamandine chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT lupojui chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT rahmanzadehreza chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT benkertpascal chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT larosafrancesco chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT bachcuadrameritxell chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT satipascal chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT theaudinmarie chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT potcaroline chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT vanpeschvincent chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT leppertdavid chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT stadelmannchristine chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT kapposludwig chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT dupasquierrenaud chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT reichdaniels chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT absintamartina chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis AT granzieracristina chronicwhitematterinflammationandserumneurofilamentlevelsinmultiplesclerosis |